Literature DB >> 6418086

Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders.

M DeGré, O J Mellbye, O Clarke-Jenssen.   

Abstract

Moderate titres of antiviral activity were demonstrated in 48-58% of sera obtained from patients suffering from seropositive and seronegative rheumatoid arthritis (RA), psoriatic arthritis, Reiter's syndrome, ankylosing spondylitis, and juvenile rheumatoid arthritis. Sera from blood donors and from patients with various noninflammatory diseases were positive in 16% of cases. The activity was species-specific, mediated by the homologous cells, and destroyed by treatment with trypsin and exposure to pH 2. Antibodies against human IFN-alpha did not neutralise the activity. These characteristics are compatible with those of IFN-gamma or immune interferon. Neither the presence nor the titre of IFN was correlated with disease activity defined by concentration of C-reactive protein, C3 concentration, and erythrocyte sedimentation rate. IFN-gamma was present in 4 of 10 synovial fluids from patients with RA. The titre in one of these was higher than in the corresponding serum, indicating local production in the rheumatoid joint.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418086      PMCID: PMC1001327          DOI: 10.1136/ard.42.6.672

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Interferon in the serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders.

Authors:  M Degré; H Dahl; B Vandvik
Journal:  Acta Neurol Scand       Date:  1976-02       Impact factor: 3.209

Review 3.  Mitogen and antigen induction of interferon in vitro and in vivo.

Authors:  L B Epstein
Journal:  Tex Rep Biol Med       Date:  1977

4.  Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens.

Authors:  L B Epstein; H W Kreth; L A Herzenberg
Journal:  Cell Immunol       Date:  1974-06       Impact factor: 4.868

5.  A micro assay for mouse and human interferon.

Authors:  H Dahl; M Degré
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Lymphokines in the rheumatoid joint.

Authors:  P Stastny; M Rosenthal; M Andreis; M Ziff
Journal:  Arthritis Rheum       Date:  1975 May-Jun

8.  Human gamma interferon production by leukocytes induced with monoclonal antibodies recognizing T cells.

Authors:  P von Wussow; C D Platsoucas; M Wiranowska-Stewart; W E Stewart
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

9.  Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis.

Authors:  J H Dobloug; O Førre; T K Kvien; T Egeland; M Degré
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

10.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  24 in total

1.  Phenotypic analysis of functionally associated molecules on peripheral blood and synovial fluid monocytes from arthritis patients.

Authors:  S J Gadd; T Felzmann; O Majdic; D Maurer; P Petera; W J Chen; J Smolen; W Knapp
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 2.  Clinical pharmacokinetics of interferons.

Authors:  R J Wills
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Authors:  S L Saidman; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

Review 4.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

5.  Augmentation of the human monocyte/macrophage chemiluminescence response during short-term exposure to interferon-gamma and tumour necrosis factor-alpha.

Authors:  L M Kumaratilake; A Ferrante; E J Bates; I C Kowanko
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

6.  Mechanisms of macrophage activation in rheumatoid arthritis: the role of gamma-interferon.

Authors:  M G Ridley; G S Panayi; N S Nicholas; J Murphy
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

7.  Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma.

Authors:  E M Lemmel; D Brackertz; M Franke; W Gaus; P W Hartl; K Machalke; H Mielke; H J Obert; H H Peter; J Sieper
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

8.  Comparative and combined effects of transforming growth factors alpha and beta, interleukin-1 and interferon-gamma on rheumatoid synovial cell proliferation, glycolysis and prostaglandin E production.

Authors:  D J Taylor; M Feldmann; J M Evanson; D E Woolley
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

9.  Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.

Authors:  K Hashimoto; C E Whitehurst; T Matsubara; K Hirohata; P E Lipsky
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

10.  Cytokine enhancement of monocyte/synovial cell attachment to the surface of cartilage: a possible trigger of pannus formation in arthritis.

Authors:  H Ishikawa; O Ohno; R Saura; T Matsubara; T Kuroda; K Hirohata
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.